Johanna Gassler, PhD student in the lab of Kikue Tachibana receives the prestigious L'ORÉAL fellowship

Master student Jasper van Schelt from Utrecht University will be joining the Knoblich lab in October. His aim is to join a team who study the underlying mechanisms of the rare disease tuberous sclerosis, using organoid models. Instead of taking the…

This year’s “Kirsten Peter Rabitsch Award” was presented to Julia Batki from the lab of Julius Brennecke

IMBA group leader Alejandro Burga has been awarded the Starting Grant of the European Research Council, endowed with approximately 1.5 million euros, for his research into selfish genetic elements called toxin-antidote systems.

Using an unbiased labelling technique, mathematical modelling, and single cell profiling to trace the footsteps of stem cells and their daughters, researchers at the University of Cambridge (UK), DGIST (S.Korea), and IMBA (Institute of Molecular…

Researchers at IMBA - Institute for Molecular Biotechnology of the Austrian Academy of Sciences – describe “adaptive radiation” of RNA export proteins. Their findings show how a small RNA pathway utilizes and re-purposes preexisting building blocks…

a:head bio AG, an Austrian biotech company focusing on the development of next generation therapeutics for the treatment of brain disorders based on human cerebral organoids has recently been incorporated.

Advances in sequencing technology have allowed scientists to peer inside living cells and follow the fate of small RNAs. The expedition has uncovered new mechanisms concerning small RNA production, their assembly into gene-regulatory complexes, and…

Researchers at IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Sciences show how neural stem cells determine their “age”, or temporal identity, which is an important prerequisite for healthy brain development.

On June 4th and 5th, EMBO fellows got together at IMP and IMBA.